Helen Torley insider trades

Open-market stock purchases and sales by Helen Torley, PRESIDENT AND CEO at Halozyme Therapeutics, Inc, from SEC Form 4 filings since Aug 29, 2011.

Recent trades

DateStockTradeValue
Sep 11, 2026HALO Halozyme Therapeutics, IncSold$1.7M
Sep 11, 2026HALO Halozyme Therapeutics, IncSold$485K
Sep 11, 2026HALO Halozyme Therapeutics, IncBought (not open market)$368K
Sep 10, 2026HALO Halozyme Therapeutics, IncSold$1.6M
Sep 10, 2026HALO Halozyme Therapeutics, IncSold$582K
Sep 10, 2026HALO Halozyme Therapeutics, IncBought (not open market)$368K
Sep 9, 2026HALO Halozyme Therapeutics, IncSold$1.4M
Sep 9, 2026HALO Halozyme Therapeutics, IncSold$711K
Sep 9, 2026HALO Halozyme Therapeutics, IncSold$10.9K
Sep 9, 2026HALO Halozyme Therapeutics, IncBought (not open market)$368K
Aug 19, 2026HALO Halozyme Therapeutics, IncSold$766K
Aug 19, 2026HALO Halozyme Therapeutics, IncSold$1M
Aug 19, 2026HALO Halozyme Therapeutics, IncSold$345K
Aug 19, 2026HALO Halozyme Therapeutics, IncBought (not open market)$368K
Aug 18, 2026HALO Halozyme Therapeutics, IncSold$588K
Aug 18, 2026HALO Halozyme Therapeutics, IncSold$510K
Aug 18, 2026HALO Halozyme Therapeutics, IncSold$986K
Aug 18, 2026HALO Halozyme Therapeutics, IncBought (not open market)$368K
Aug 17, 2026HALO Halozyme Therapeutics, IncSold$89.1K
Aug 17, 2026HALO Halozyme Therapeutics, IncSold$50.2K
Aug 17, 2026HALO Halozyme Therapeutics, IncSold$214K
Aug 17, 2026HALO Halozyme Therapeutics, IncSold$923K
Aug 17, 2026HALO Halozyme Therapeutics, IncSold$776K
Aug 17, 2026HALO Halozyme Therapeutics, IncBought (not open market)$368K
Jul 8, 2026HALO Halozyme Therapeutics, IncSold$70.4K

Companies traded

  • HALO Halozyme Therapeutics, Inc: 1 buy, 178 sales, last Sep 11, 2026
  • DGX Quest Diagnostics Inc: other filings, last May 25, 2021
  • RLYP Relypsa Inc: 1 sale, last Sep 1, 2016
  • ONXX Onyx Pharmaceuticals Inc: 13 sales, last Oct 1, 2013

Get free alerts when Helen Torley files a new trade →